Clinical Trial Update: Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on NVDX3 for degenerative lumbar spondylolisthesis; a Phase 1/Phase 2 study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Lumbar Spondylolisthesis

Drugs mentioned

• NVDX3

Snippet

Sponsor: Novadip Biosciences | Conditions: Degenerative Lumbar Spondylolisthesis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING